LENSAR, Inc. (LNSR)

Market Cap	68.95M -58.6%
Revenue (ttm)	58.44M +9.2%
Net Income	-34.28M
EPS	-2.87
Shares Out	12.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,039
Open	5.49
Previous Close	5.46
Day's Range	5.45 - 5.70
52-Week Range	5.33 - 14.31
Beta	0.99
Analysts	Strong Buy
Price Target	10.00 (+76.37%)
Earnings Date	May 7, 2026

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 150
• Stock Exchange: NASDAQ
• Ticker Symbol: LNSR
• Website: https://www.lensar.com

Financial Performance

In 2025, LENSAR's revenue was $58.44 million, an increase of 9.24% compared to the previous year's $53.49 million. Losses were -$34.28 million, 9.16% more than in 2024.

Analyst Summary

According to one analyst, the rating for LNSR stock is "Strong Buy" and the 12-month stock price target is $10.0.

Price Target

$10.0

(76.37% upside)

Analyst Consensus: Strong Buy